|
[1]郭晓钟, 于世远, 郭萍, 等.ELISA法检测血清胰腺癌胚抗原对胰腺癌诊断的价值[J].中华消化杂志, 1989, 9 (2) :88-91.
|
|
[2]郭晓钟, 刘民培.免疫放射化析法检测血清SC6抗原对胰腺癌诊断的评价[J].中华内科杂志, 1992, 31 (2) :84-86.
|
|
[3]郭晓钟, 刘民培, 刘志凡, 等.SC6抗原在胰腺癌等胸腹水中的检测水平[J].中华核医学杂志, 1993, 13 (4) :243.
|
|
[4]郭晓钟, 林一帆, 赵学良, 等.血清SC6抗原、B超及CT对胰腺癌诊断的价值[J].中华消化杂志, 1994, 14 (5) :314-315.
|
|
[5]Friess H, Guo XZ, Nan BC, et al.Growth factors and cyto-kines in pancteatic carcinogenesis[J].Annals New York A-cademy Sciences, 1999, 880:110-121.
|
|
[6]Guo XZ, Shao XD, Liu MP et al.Gene mutations are presentonly in advanced pancreatic cancer[C].The third Confer-ence on Japan-sino endoscopy and gastroenterology, 2001, 5:46-50.
|
|
[7]Friess H, Zhao L, Graber HU, et al.Expression of the signa-ling TGF-beta receptor correlates with advanced tumorstage in pancreatic cancer[J].Gastroenterology, 1997, 112 (4) :A564-A564.
|
|
[8]Friess H, Guo XZ, Tempia-caliera AA, et al.Differential ex-pression of metastasis-associated genes in papilla of vaterand pancreatic cancer correlates with disease stage[J].JClin Oncol, 2001, 19 (9) :2422-2432.
|
|
[9]Lu Z, Friess H, Graber HU, et al.Presence of two signalingTGF-βreceptors in human pancreatic cancer correlates withadvanced tumor stage[J].Dig Dis Sci, 1997, 42 (10) :2054-2063.
|
|
[10]Guo XZ, Friess H, Graber HU, et al.KAI1 expression is up-regulated in early pancreatic cancer and decreased in thepresence of metastases[J].Cancer Res, 1996, 56 (21) :4876-4880.
|
|
[11]Guo XZ, Friess H, Maurer C, et al.KAI1 is unchanged inmetastatic and nonmetastatic esophageal and gastric cancers[J].Cancer Res, 1998, 58 (4) :753-758.
|
|
[12]Guo XZ, Friess H, Di Mola FF, et al.KAI1, a new metasta-sis suppressor gene, is reduced in metastatic hepatocellularcarcinoma[J].Hepatology, 1998, 28 (6) :1481-1488.
|
|
[13]Friess H, Guo XZ, Berberat P, et al.Reduced KAI1 expressionin pancreatic cancer is associated with lymph node and distantmetastases[J].Int J Cancer, 1998, 79 (4) :349-355.
|
|
[14]Mu ZB, Wang H, Zhang J, et al.KAI1/CD82 suppresseshepatocyte growth factorinduced migration of hepatoma cellsvia upregulation of Sprouty2[J].Sci China C Life Sci, 2008, 51 (7) :648-657.
|
|
[15]Guo XZ, Xu JH, Liu MP, et al.KAI1 inhibits anchorage-de-pendent and–independent pancreatic cancer cell growth[J].Onco Rep, 2005, 14 (1) :59-63.
|
|
[16]Wu CY, Yan J, Yang YF, et al.Overexpression of KAI1 in-duces autophagy and increases MiaPaCa-2 cell survivalthrough the phosphorylation of extracellular signal-regulatedkinases[J].Biochem Biophys Res Commun, 2011, 404 (3) :802-808.
|
|
[17]Ren LN, Li QF, Xiao FJ, et al.Endocrine glands-derivedvascular endothelial growth factor protects pancreatic cancercells from apoptosis via upregulation of the myeloid cell leu-kemia-1 protein[J].Biochem Biophys Res Commun, 2009, 386 (1) :35-39.
|
|
[18]邵丽春, 郭晓钟, 徐建华, 等.β-catenin, c-myc和CyclinD1在胰腺癌组织中的表达及意义[J].胰腺病学, 2005, 12 (5) :210-213.
|
|
[19]Chen J, Li HY, Wang D, et al.Human dendritic cells trans-fected with amplified MUC1 mRNA stimulate CTL responsesagainst pancreatic cancer[J].J Gastroenterol Hepatol, 2011, 26 (10) :1509-1518.
|
|
[20]Xu JH, Guo XZ, et al.KAI1 is potential target on anti-me-tastasis in pancreatic cancer cells[J].World J Gastroen-terol, 2008, 14 (6) :1126-1132.
|
|
[21]李晓姝, 郭晓钟, 任丽楠, 等.胰腺癌207例临床病理特征分析[J].实用癌症杂志.2010, 25 (6) :638-641.
|
|
[22]Liu MP, Guo XZ, Xu JH, et al.New tumor-associated anti-gen SC6 in Pancreatic cancer[J].World J Gastroenterol, 2005, 7671-7675.
|
|
[23]Guo XZ, Cui ZM.Current diagnosis and treatment of pancre-atic cancer in China[J].Pancreas, 2005, 31 (1) , 13-22.
|
|
[24]李宏宇, 郭晓钟, 张丹阳, 等.动态MRCP诊断慢性胰腺炎的价值[J].中国消化内镜, 2008, 2 (7) :28-30.
|
|
[25] 郭晓钟.胰腺癌治疗的现状、难点与对策[J].中华内科杂志, 2010, 4 (29) :283-284.
|
DownLoad: